MedPath

Propylthiouracil

Propylthiouracil Tablets, USP

Approved
Approval ID

a57c49ae-d659-49fa-84e3-cf6d1f9e6f97

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Oct 31, 2021

Manufacturers
FDA

Actavis Pharma, Inc.

DUNS: 119723554

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Propylthiouracil

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code0228-2348
Application NumberANDA080172
Product Classification
M
Marketing Category
C73584
G
Generic Name
Propylthiouracil
Product Specifications
Route of AdministrationORAL
Effective DateOctober 31, 2021
FDA Product Classification

INGREDIENTS (6)

PROPYLTHIOURACILActive
Quantity: 50 mg in 1 1
Code: 721M9407IY
Classification: ACTIB
LACTOSE MONOHYDRATEInactive
Code: EWQ57Q8I5X
Classification: IACT
SILICON DIOXIDEInactive
Code: ETJ7Z6XBU4
Classification: IACT
STARCH, CORNInactive
Code: O8232NY3SJ
Classification: IACT
POVIDONEInactive
Code: FZ989GH94E
Classification: IACT
MAGNESIUM STEARATEInactive
Code: 70097M6I30
Classification: IACT

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.